Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral isothiourea catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118638038A reveals mild catalytic synthesis for high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability advantages.
Patent CN118638038B reveals novel chiral isothiourea catalysis for high-purity indole amides. Enables cost reduction and scalable supply chain for pharmaceutical intermediates manufacturing.
Patent CN121045008A enables high-purity axial chiral biaryl amino phenol synthesis under mild conditions avoiding heavy metals for cost-effective pharmaceutical intermediate manufacturing.
Patent CN118638038B delivers high-yield synthesis of N-axis chiral indole amides with exceptional enantioselectivity enabling cost reduction in pharmaceutical manufacturing and robust supply chain solutions.
Recent patent reveals chiral isothiourea-catalyzed synthesis of N-axis chiral indole amides with mild conditions and high enantioselectivity enabling cost reduction and reliable supply for pharmaceutical intermediates.
Discover a scalable, high-yield synthesis of N-axis chiral indole amides with >95% ee and potent Hep G2 cytotoxicity. Reduce R&D costs and supply chain risks with our CDMO expertise.